Centre for Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester and St. Mary's Hospital, Manchester Academic Health Science Centre, Manchester, UK.
Am J Hum Genet. 2013 Feb 7;92(2):259-64. doi: 10.1016/j.ajhg.2012.12.002. Epub 2013 Jan 11.
Urofacial syndrome (UFS) (or Ochoa syndrome) is an autosomal-recessive disease characterized by congenital urinary bladder dysfunction, associated with a significant risk of kidney failure, and an abnormal facial expression upon smiling, laughing, and crying. We report that a subset of UFS-affected individuals have biallelic mutations in LRIG2, encoding leucine-rich repeats and immunoglobulin-like domains 2, a protein implicated in neural cell signaling and tumorigenesis. Importantly, we have demonstrated that rare variants in LRIG2 might be relevant to nonsyndromic bladder disease. We have previously shown that UFS is also caused by mutations in HPSE2, encoding heparanase-2. LRIG2 and heparanase-2 were immunodetected in nerve fascicles growing between muscle bundles within the human fetal bladder, directly implicating both molecules in neural development in the lower urinary tract.
尿道-面综合征(UFS)(或奥乔亚综合征)是一种常染色体隐性遗传病,其特征为先天性膀胱功能障碍,肾功能衰竭风险显著增加,以及微笑、大笑和哭泣时出现异常的面部表情。我们报告称,一部分 UFS 患者存在 LRIG2 基因的双等位基因突变,该基因编码富含亮氨酸重复序列和免疫球蛋白样结构域 2,该蛋白参与神经细胞信号传递和肿瘤发生。重要的是,我们已经证明 LRIG2 中的罕见变异可能与非综合征性膀胱疾病有关。我们之前已经表明,UFS 也由 HPSE2 基因突变引起,该基因编码肝素酶-2。LRIG2 和肝素酶-2 在人类胎儿膀胱内的肌束之间生长的神经束中被免疫检测到,这直接表明这两种分子都参与了下尿路的神经发育。